CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 1, February 2012
56
AFRICA
ment of specific situations, including
hypertensive emergency and urgency,
severe hypertension with target-organ
damage, hypertension in diabetes melli-
tus, and resistant hypertension. Drug
interactions are also cited within the
guidelines.
J Aalbers
1.
Seedat YK, Rayner BL. South African
Hypertension Guideline 2011.
S Afr Med J
2012;
102
: 57–84.
2.
Opie LH, Steyn K. Rationale for the hyper-
tension guidelines for primary care in South
Africa.
S Afr Med J
1995;
85
(12 Part 2):
1325–1328.
3.
Southern African Hypertension Society,
Executive committee 2000.
S Afr Med J
2001;
91
(2 Part 2): 163–172.
4.
FJ Milne, FJ Pinkney Atkinson for the
Southern African Hypertension Society
Guideline Working Group 2000 & 2003.
Hypertension guideline 2003 update.
S Afr
Med J
2004;
94
: 209–226. (Partially updated
from 2001 only with regard to measurement
of BP, sustainable hypertension manage-
ment and scarce resources, and compelling
indications for specific drug class.)
5.
Joint National Hypertension Guideline
Working Group 2006. South African
Hypertension Guideline 2006.
S Afr Med J
2006;
96
(4 Part 2): 337–362.
6.
Kred T,
et al.
Clinical Practice Guidelines
within the Southern African Development
Community; a descriptive study of the qual-
ity of guideline development and concord-
ance with best evidence for five prior-
ity diseases.
Health Research Policy and
Systems
2012;
10
: 1 (doi:10.1186/1478-
4505-10-1).
7.
Mancia G,
et al
. Reappraisal of European
Guidelines on Hypertension Management:
a European Society of Hypertension task
force Document.
J Hypertens
2009;
27
:
2121–2158.
